MedTrace Logo

Safety and Initial Feasibility of Using the Neurolyser for Facet Related Low Back Pain

NCT03321344 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-01-25

No results posted yet for this study

Summary

Single arm pilot study to evaluate the safety and initial feasibility of the Neurolyser XR, a new portable high intensity focused ultrasound device, for noninvasive thermal ablation of medial nerve branches of painful lumbar facet joint/s

Conditions

  • Facet Related Low Back Pain

Interventions

DEVICE

Focused Ultrasound Thermal ablation

Focused Ultrasound Thermal ablation of the Medial Nerve Branch

Sponsors & Collaborators

  • Focused Ultrasound Foundation

    collaborator OTHER

  • FUSMobile Inc.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-12-05
Primary Completion
2019-02-28
Completion
2020-02-19

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03321344 on ClinicalTrials.gov